COVID-19 - Collection of articles on the Coronavirus outbreak
Vol. 90 No. 3 (2020)
https://doi.org/10.4081/monaldi.2020.1437

COVID-19 and tuberculosis co-infection: a neglected paradigm

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 8 June 2020
Published: 4 September 2020
8897
Views
4277
Downloads
COVID-19, tuberculosis, coinfection, India

Authors

Arkapal Bandyopadhyay
https://orcid.org/0000-0001-9755-0233
Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, India.
Sarika Palepu
sarikapalepu@gmail.com
https://orcid.org/0000-0001-6534-2149 (unauthenticated)
Department of Community Medicine, VCSGGMS and RI, Srinagar, India.
Krishna Bandyopadhyay
Saint Teresa Kolkata Memorial TB Hospital, Kolkata, India.
Shailendra Handu
Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, India.

COVID-19 has been affecting mankind round the globe. The incidence of this infectious disease of respiratory origin is constantly on rise. Another infectious disease widely prevalent is tuberculosis (TB). During past corona virus pandemics of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome, coinfection with TB was seen. We present this review as the co-infection of COVID-19 with TB has not been assessed yet, imposing a greater global threat. We suggest few measures to be implemented without delay for effectively screening the suspects of co-infection and also follow up of non-suspect patients in the post-pandemic phase.

Downloads

Download data is not yet available.

How to Cite



“COVID-19 and Tuberculosis Co-Infection: A Neglected Paradigm”. 2020. Monaldi Archives for Chest Disease 90 (3). https://doi.org/10.4081/monaldi.2020.1437.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.